Rockefeller Capital Management L.P. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$48
-99.9%
1,2280.0%0.00%
Q3 2022$58,000
-12.1%
1,228
-28.3%
0.00%
Q2 2022$66,000
-8.3%
1,713
+35.4%
0.00%
Q1 2022$72,000
-25.8%
1,265
+3.0%
0.00%
Q4 2021$97,000
-8.5%
1,2280.0%0.00%
-100.0%
Q3 2021$106,000
-32.9%
1,2280.0%0.00%0.0%
Q2 2021$158,000
+61.2%
1,2280.0%0.00%0.0%
Q1 2021$98,000
-2.0%
1,2280.0%0.00%0.0%
Q4 2020$100,000
+426.3%
1,228
+53.5%
0.00%
Q3 2020$19,0008000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HSG Holding Ltd 1,127,934$31,582,0005.60%
Omega Fund Management, LLC 302,821$8,479,0002.32%
Redmile Group, LLC 3,356,958$93,995,0001.74%
BRANDYWINE MANAGERS, LLC 10,875$305,0001.25%
DC Investments Management, LLC 88,100$2,467,0000.91%
Alphabet Inc. 663,691$18,583,0000.86%
Cormorant Asset Management, LP 796,429$22,036,0000.84%
HHLR ADVISORS, LTD. 2,966,403$83,059,0000.76%
Temasek Holdings (Private) Ltd 3,354,641$93,930,0000.56%
Granahan Investment Management 96,598$2,705,0000.10%
View complete list of BEAM THERAPEUTICS INC shareholders